Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serostim and Avandia in HIV-Associated Visceral Adiposity
NCT00130286Phase 2Completed
- Sponsor
- Weill Cornell Medicine
- Start
- Mar 2005
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of somatropin, rosiglitazone in HIV-associated lipodystrophy (HALS), insulin resistance (IR), sponsored by Weill Cornell Medicine. Started Mar 2005; status: completed.
02
Drugs
somatropinrosiglitazone
03
Conditions
HIV-associated lipodystrophy (HALS)insulin resistance (IR)
Beyond the preview
Go deeper on NCT00130286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00130286.